AI-generated summary
The authors studied low level laser therapy at 660 nm, with fluences from 2 to 10 J/cm2, on HIV-1 infected and uninfected TZM-bl cells in the laboratory. They report no changes in uninfected cells, while infected cells showed altered morphology, reduced luciferase activity and dose-dependent cell damage.
- Who or what was studied
- HIV-1 infected and uninfected TZM-bl cells (laboratory cell culture)
- Wavelengths
- 660 nm
- Limits stated in the abstract
- The study used cultured cells only, so the abstract provides no evidence about effects in people with HIV-1.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on onlinelibrary.wiley.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 660 nm
- Energy density (fluence)
- 2 J/cm2, 10 J/cm2
How to read a single study: what to check before relying on this kind of research.
Terms in this paper: Laser, Low-level laser therapy, Wavelength, Dose. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.